TRIM involvement in transcriptional regulation

Advances in Experimental Medicine and Biology

Volumn 770, Issue , 2012, Pages 59-76

  Cammas, Florence ^a   Khetchoumian, Konstantin ^a   Chambon, Pierre ^a   Losson, Régine ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; KRUPPEL ASSOCIATED BOX ZINC FINGER PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; REGULATOR PROTEIN; REPRESSOR PROTEIN; RET FINGER PROTEIN; SMAD PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION INTERMEDIARY FACTOR 1; TRANSCRIPTION INTERMEDIARY FACTOR 1ALPHA; TRANSCRIPTION INTERMEDIARY FACTOR 1BETA; TRANSCRIPTION INTERMEDIARY FACTOR 1GAMMA; TRIPARTITE MOTIF PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; PROTEIN;

ARTICLE; GENE CONTROL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION; ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; METABOLISM; PROTEIN MOTIF; REVIEW;

AMINO ACID MOTIFS; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; PROTEINS; TRANSCRIPTION, GENETIC;

MLCS; MLOWN;

EID: 84878950821     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-5398-7_5     Document Type: Article

References (106)

1. I. Li 13, Carey M, Workman JL. The role of chromatin during transcription. Cell 2007; 128:707-719.
2. Berger SL. The comple x language ofchrom atin regulation during transcription. Nature 200 7; 447:40 7-412.
3. Beckstead R,Ortiz JA, Sanchez C, et al. Bonus, a Drosophil a homolog ofTlFI proteins, interact s with nuclear receptors and can inhibit FTZ -F I -de pe n d e nt transcription. Mol Cell 2001; 7:753-765.
4. Kiefer JC, Smith PA, Mango SE. PI-IA-4/FoxA cooperates withTAM-I/TRIMto regulate cell fate restriction in the C. elegans foregut. Dev BioI 2007; 303:611-624.
5. Lc Douarin 13, Zec hcl C, Garnier JM et al. The N-tcrm inal part of Tl FI, a putativ e mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T 18. EM130 J 1995; 14:2020-2033.
6. Friedman JR, Fredericks WJ, Jensen DE, et al. 1. KAP-I, a novel corepressor for the highly conserved KRAB repression domain. Genes Dev 1996; 10:2067-2078.
7. Zhong S, Salomoni L, Pandolfi PI'. The transcriptional control of PML and the nuclear body. Nat Cell BioI 2000; 2:85-89.
8. Le Douarin B, Nielsen AL, Garni er JM, et al. A possible involvement of Tl Fl a and Tl FI in the epigenetic control oftranscription by nuclear receptors. EMBO J 1996; 15:6701-6715.
9. Nielsen AL, Ortiz JA, You Jet al. Interac tion with members of the heterochromatin protein I (HPI) family and histone deacetylation are differentially involved in transcriptional silencing by members ofthe TIF I family. EMBO J 1999; 18:6385-6395 .
10. Schultz DC, Friedman JR, Rauscher III FJ. Targeting histone deacetylase complexes via KRA13-zinc finger proteins: the PHD and bromodomains ofKAP-I form a cooperative unit that recru its a novel isoform of the Mi-2alph a subunit ofNuRD. Genes Dev 200 I; 15:428-443
11. Schultz DC, Ayya nathan K, Negorev D, et al. SETDBI: a novel KAP-I-associated histone H3, lysine 9-spec ific mcthyltransferasc that contributes to HPI-mediatcd silencing of euchroma tic genes by KRA13 zinc-finger proteins. Genes Dev 2002; 16:919-932.
12. Khetchoumian K, Teletin M, Mark M, et al. TlFI0, a novel lIP I-interacting member ofthe transcriptio nal intermediary factor I (TIFI) family expressed by elongating spermatids. J BioI Chern 2004; 279: 48329-48341.
13. Wu WS, Vallian S, Seto E, et al. The growth suppressor pml represses transcript ion by functionally and physically interacting with histone deacetylases. Mol Cell Bioi 200 I ; 21:2259-2268.
14. Shimono Y, Murakami H, Hasegawa Y, et al. RET finger protein is a transcr iptional repressor and interacts with enhancer ofpolycomb that has dual tran scriptional functions. J BioIChern 2000 ; 275:394 11-394 19.
15. Yan K, Dolle L, Mark M, et al. Molecular cloning, genomic structure and expression analys is of the mouse transcriptional intermedi ary factor I gamma gene. Gene 2004; 334:3-13.
16. Ventur ini L, You J, Stadler M, et al. TIF ly, a novel member of the transcriptional intermediary factor I family. Oncogene 1999; 18:1209-121 7.
17. Klugbauer S, Rabes HM. The transcription coactivator HTIFI and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas. Oncogene 1999; 18:4388-4 393.
18. Khetchoumian K, Teletin M, Tisserand J, et al. Loss of Trim24 (Tifl a) gene function confers oncogenic activity to retinoic acid receptor alpha . Nat Genet 2007; 39:1500-1506.
19. Ignat M, Teletin M, Tisserand Jet al. Arteria l calci fications and increased expression of vitamin D receptor targets in mice lacking T1Fl a . Proc Nat! Acad Sci USA 2008; 105:2598-2603.
20. Cammas F, Mark M, Dolle I', et al. Mice lacking the transcriptional corcprcssor Tlf' Ip are defective in early postimplantation development. Development 2000; 127:2955-2963.
21. Weber L, Cammas F, Gerard C, et al. Germ cell expression of the transcriptional corepressor Tl FI is required for the maintenance of spermatogenesis in the mouse. Development 2002 ; 129:2329-2337.
22. He W, Dorn DC, Erdj ument -Bromage H, et al. Hematopoiesis controlled by dist inct TIFly and Smad4 branches ofthe TGF pathway. Cell 2006; 125:929-941.
23. Dupont S, Zacchigna L, Cordenonsi M, et al. Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell 2005; 121:87-99.
24. Ransom DG, Bahary N, Niss K, et al. The zebrafish moonshine gene encode s transcriptional intermed iary factor I gamma, an essential regulator of hematopoiesis. PLoS Bioi 2004; 2:E237.
25. Peng H, Begg GE, Schultz DC, et al. Reconstitution of the KRAB-KAPI repressor comple x: a model system for defining the molecular anatomy of RING-B box-coiled-coil domain-mediated protein-protein interact ions. J Mol BioI 2000 ; 295:1139-11 62.
26. Peng 1-1, Feldman I, Rauscher FJ 3rd. Hctero-oligomerization among the T1F family of R13CC/TRIM domain-containing nuclearc ofactors: a potential mechanism for regulating the switch between coactivation and corepress ion. J Mol BioI 2002; 320:629-644.
27. Mellor J. It takes a PHD to read the histone code. Cell 2006; 126:22-24.
28. Mujtaba S, Zeng L, Zhou MM. Structure and acety l-lysine recog nition of the bromodomain. Oncogene 2007; 26:5521-5527.
29. Fraser RA, Heard OJ, Adam Se tal. The putative cofactor TIFIa is a protein kinase that is hyperp hosphorylated upon interaction with liganded nuclear receptors. J Bioi Chern 1998; 27:16199-16204.
30. Underh ill C, Qutob MS, Yee SP, et al. A nove l nuclear receptor corepressor complex, N-CoR, conta ins components of the mammalian SWIISNF complex and the corepressor KAP-1. J Bioi Chem 2000 ; 275:40463 -40470.
31. Hediger F, Gasser SM. Heterochromatin protein 1: don't j udge the book by its cover ! Curr Opin Genet Dev 2006; 16:143-150.
32. Kwon SH, Workman JL. The heterochromatin protein 1 (HP1) family: put away a bias toward HPI. Mol Cells 2008; 26:217-227.
33. Ryan RF, Schultz DC, Ayya nathan K, et al. KAP-1 corepressor protein interacts and colocalizes with heterochromatic and euchromatic HPI proteins: a potential role for Kriippel-associated box-zinc finger proteins in heterochromatin-mediated gene silencing. Mol Cell Bioi 1999; 19:4366-4378 .
34. Mange lsdorf OJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell 1995; 83:835 -839 .
35. Lonard OM, O'Malley BW. Nuclear receptor coregu lators : j udges, ju ries and exec utioners of cellular regulation. Mol Cell 2007; 27:691-700 .
36. Zhong S, Delva L, Rachez C, et al. A RA-depe ndent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoprot eins . Nat Genet 1999; 23:287-295.
37. Teyssier C, Ou CY, Khetchoumian K, et al. Transcriptional intermediary factor I a mediates physical interaction and functio nal synergy between the coactivator-associated arginine methyltransferase 1 and glucocorticoid receptor-interacting protein I nuclear receptor coactivators . Mol Endocrinol 2006; 20:1276-1286.
38. Khetchoumian K, Teletin M, Tisserand J, et al. Trim24 (Tiff a): an essen tia l 'b rake ' forretinoic acid-induced transcri ption to prevent liver cancer. Cell Cycle 2008; 7:3647-365 2.
39. Iluntley S, Baggott OM, Hamilton AT, et al. A comprehe nsive catalog of human KRAB-assoc iated zinc finger genes: insights into the evolutionary history ofa large family oftrans criptional repressors. Genome Res 2006; 1:669-677.
40. Abrink M, Ortiz JA, Mark C, et al. Conserved interaction between distinct Kriippel-associated box domains and the transcriptional intermed iary factor I 13. Proc Natl Acad Sci USA 2001; 98: 1422-1426.
41. Ivanov AV, Peng H, Yurchenko V, et al. PHD domain-mediated E3 ligase activity directs intramol ecular sumoylation of an adjacent bromodomain required for gene silencing. Mol Cell 2007; 28:823 -837 .
42. Ayyanathan K, Lechner MS, Bell P, et al. Regulated recruitm ent of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation. Genes Dev 2003; 17:1855-1869.
43. Sripathy SP, Stevens J, Schultz DC. The KAPI corepressor functions to coordinate the assembly ofde novo HPI-demarcated microenvironments ofheterochromatin required for KRAB zinc finger protein-mediated transcriptional repression. Mol Cell Bioi 2006; 26:8623 -8638 .
44. Riclet R, Chendeb M, Vonesch JL, et al. Disruption ofthe interaction between transcri ptional intermediary factor I 13 and heterochromatin protein I leads to a switch from DNA hyper-to hypomethylation and H3K9 to H3K27 trimethylation on the MEST promoter correlating with gene reactivation. Mol Bioi Cell 2009; 20:296-305.
45. Cammas F, Oulad-Ab delgha ni M, Vonesch JL, et al. Cell differentiation induces TIFl f3 association with centrome ric heteroc hromatin via an HPI interaction. J Cell Sci 2002; 115:3439-3448.
46. Cammas F, Herzog M, Lerouge T, et al. Association of the transcriptio nal corepressor TlF1f3 with heterochromatin protein I (l IP I): an essential role for progression through differentiation. Genes Dev 2004; 18:2147-2160.
47. Wolf 0, Goff SP. TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell 2007; 131:46-57.
48. Wolf 0, Cammas F, Losson R, et al. Primer binding site-depe ndent restriction of murine leukemia virus requires HPI binding by TRIM28. J Virol 2008; 82:4675-4679 .
49. O'Geen 1-1, Squazzo SL, Lyengar S, et al. Genome-wide analysis ofKAPI binding suggests autoreg ulation ofKRAB-ZNFs. PloS Genet 2007 ; 3:e89 .
50. Wang C, Ivanov A, Chen L, et al. MDM2 interac tion with nuclear corep ressor KAPI contributes to p53 inactivation. EMBO J 2005; 24:3279-3290.
51. Wang C, Rauscher FJ, Cress WD, et al. Regulation ofE2F I function by the nuclear corepressor KAPI. J Bioi Chem 2007; 282:29902 -29909 .
52. Fazzio TG, Huff JT, Panning B.An RNAi screen ofchromatin proteins identifies Tip60-p400 as a regulator of embryo nic stem cell identity . Cell 2008; 134:162-174.
53. Hu G, Kim J, Xu Qet al. A geno me-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev 2009; 23:837 -848.
54. Wang ZG, Delva L, Gaboli M, et al. Role of PML in cell growth and retinoic acid pathway. Science 1998; 279: 1547-1551.
55. Rego EM, Wang ZG, Peruzzi Det al. Role of promyelocytic leukemia (PML) protein in tumor suppressio n. J Exp Med 2001; 193:521-529 .
56. Je nssen K, Shiels C, Freemo nt PS. PML protein isoforms and the RBCCnRIM motif. Oncogene 2001; 20:7223-7233.
57. Berna rdi R, Pandolfi PP. Structure, dynamics and functio ns of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Bioi 2007; 8: 1006-1016.
58. Boisvert FM, Kruhlak MJ, Box AK, et al. The transcri ption coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J Cell BioI 200 1; 152:1099-1 106.
59. Seeler JS,MarchioA, Siuer lin Detal.lnteractionofSP I00 with HPI proteins: ali nkbetweenthe promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Mol Cell Bioi 1998; 95:73 16-7321 .
60. LaMorte V, Dyck JA, Ochs RL, et al. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc Nat! Acad Sci USA 1998; 95:499 1-4996 .
61. Boisvert FM, Hendzel MJ, Bazeu-Jones DP. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J Cell BioI 2000; 148:283-292.
62. Wang J, Shiels C, Sasieni P, et al. Promyelocytic leukemia nuclear bodies associat e with trans criptio nally active genomic regions. J Cell Bioi 2004; 164:515-526.
63. Ching RW, Dellaire G, Eskiw CH, et al. PML bodies: A meeting place for genomic loci. J Cell Sci 2005; 118:847-854 .
64. Guiochon-Mantel A, Savouret JF, Guignon, et al. Effect of PML and PML-RAR on the transact ivation properties and subcellular distribution ofstero id hormone receptors. Mol Endocrinol 1995; 9: 1791-1803 .
65. Doucas V, Tini M, Egan DA, et al. Modulation of CREB binding protein function by the promyelocytic (PML) oncopro tein suggests a ro le for nuclear bodies in hormone signaling. Proc Nat! Acad Sci USA 1999; 96:26 27-2632.
66. Guo A, Salomoni P, Luo J, et al. The function of PML in p53-dependen t apoptosis. Nat Cell Bioi 2000; 2:730-736.
67. Bernasso la F, Oberst A, Melino G, et al. The promyelocytic leukaemia protein tumour suppressor functions as a transc riptional regulator of p63. Oncogene 2005; 24:6982-6986.
68. Bernasso la F, Salomoni L, Oberst A, et al. Ubiquitin-depe ndent degradation of p73 is inhibited by PML. J Exp Med 2004; 199:1545-1557.
69. Pearson M, Carbone R, SebastianiC, et al. PMLregula tes p53 acety lation and premature senesce nce induced by oncogenic Ras. Nature 2000; 406:207-210.
70. Kurki S, Latonen L, Laiho M. Cell ular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization. J Cell Sci 2003; 116:39 17-3925.
71. Bernar di R, Scagl ioni PI', Bergmann S, et al. PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nature Cell BioI 2004; 6:665-672.
72. Louria-Hayon I, Grossman T, Sionov RV, et al. The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation. J BioI Chern 2003; 278:33134-33141.
73. Alsheich-Bartok 0, Haupt S, Alkalay-Snir L et al. PML enhances the regulation ofp53 by CK I in response to DNA damage. Oncogene 2008; 27:3653-3661.
74. Li M, Chen D, Shiloh A, et al. Deubiquitination of p53 by I-IAUSP is an important pathway for p53 stabilization . Nature 2002; 4 16:648-653.
75. Vallian S, Gake n JA, Gingold EB, et al. Modulation ofFos -mediatedAP-I transcription by the promyelocytic leukemia protein. Oncogene 1998; 16:2843-2853.
76. Tsuzuki S, Towatari M, Siato H, et al. Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein(PML) and the t(l5; 17)-generated PML-retinoicacidreceptoroncoprotein. Mol Cell BioI 2000; 20:6276-6286.
77. Nguyen LA, Pandolfi PP, Aikawa Y, et al. Physical and functional link of the leukemia-associated factors AMLI and PML. Blood 2005 ; 105:292-300 .
78. Lin HK,Bergmann S, Pandolfi PP.Cytoplasmic PML function in TGF -signali ng. Nature 2004; 431:205-211.
79. Kumar PI', Bischof 0, Purbey PI', et al. Functional interaction between PML and SATBI reg ulates chromatin-loop architecture and transcription of the MHC class I locus. Nature Cell BioI 2004; 9:45-56.
80. Li L-L, Leo C, Zhu J, et al. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol Cell Bioi 2000; 20:1784-1796.
81. Buschbec k M, Uribesalgo I, Ledl A, et al. PML4 induces differentiation by Myc destabilization. Oncogene 2007; 26:3415-3422.
82. Vallian S, Gaken EB, Trayner, et al. Transcriptional repression by the promyelocytic leukemia protein, PML. Exp Cell Res 1997; 237:37 1-382.
83. Khan MM, Nomura T, Kim H, et al. Role of PML and PML-RARu in Mad-med iated transcriptional repress ion. Mol Cell 2001; 7:1233-1243.
84. Vallian S, Chin KV, Chang KS. The promyelocyti c leukemia protein interacts with Spl and inhibits its transactivation ofthe epiderma l growth factor receptor promoter. Mol Cell BioI 1998; 18:7147-7156.
85. Wu WS, Xu lX, Ran Ret al. Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through spec ific functional interactions. Oncogene 2002; 21:3925-3933.
86. Wu WS, Xu lX, Chang KS. The promyelocytic leukemia protein represses A20-mediated transc ription. J BioI Chem 2002; 277:31734-3 1739.
87. Choi YH, Bernard i R, Pandolfi PP, et al. The promyelocytic leukemia protein functio ns as a negative reg ulator of IFN-y signaling. Proc Natl Acad Sci USA 2006; 103:18715-18720.
88. Alcaly M, Tomassoni L, Colombo E, et al. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol Cell BioI 1998; 18:1084-1093.
89. Takahashi M, CooperGM. Ret transfo rming gene encodes a fusion protein homologous to tyrosin e kinases . Mol Cell Bioi 1987; 7: 1378-1385.
90. Tezel G, Nagasaka T, Iwahashi N, et al. Different nuclear/cytoplasmic distrib utions of RET finger protein in different cell types. Path Int 1999; 49:881-886
91. Cao T, Duprez E, Borden KLB, et al. Ret finger protein is a normal component ofPML nuclear bodies and interac ts directly with PML. J Cell Sci 1998; I II :13 19-1329.
92. Morris-Desbois C, Bochard V, Reynaud C, et al. Interaction between the Ret finger protein and the Int-6 gene product and coloca lisation into nuclear bodies. J Cell Sci 1999; 112:333 1-3342.
93. Dho SH, Kwon KS. The Ret finger protein induces apoptosis via its RING finger-B box-coiled-coil motif. J BioI Chem 2003; 278:31902-3 1908.
94. Matsuura T, Shimono Y, Kawai Ket al. PIAS proteins are involved in theSUMO-I modification, intracell ular translocation and transcriptional repressive activity of RET finger protein. Exp Cell Res 2005; 308:65 -77.
95. Fukushige S, Kondo E,GuZ, et al. RET finger proteinenhancesMBD2-andMBD4- dependent transcriptio nal repress ion. Biochem Biophys Res Commun 2006; 351 :85-92.
96. Shimono Y, Murakami H, Kawai K, et al. Mi -2 associates with BRG I and RET finger protein at the distinct regions with transcriptional activating and repressing activities . J BioI Chem 2003 ; 278:5 1638-5 1645.
97. Bloor AJ, Kotsopoulou E, Hayward P, et al. RFP represses transc riptional activation by bHLH transcription factors. Oncogene 2005; 24:6729-6736.
98. Krutzfeldt M, Ellis M, Weekes DB, et al. Selectiv e ablation of Retinoblastoma protein function by the RET finger protein. Mol Cell 2005; 18:213-224.
99. Townson SM, Kang K, Lee AVet al. Novel role of the RET finger protein in estrogen receptor -mediated transcription in MCF-7 cells . Biochcm Biophys Res Commun 2006; 349:540-548.
100. ShimonoK, Shimo noY, ShimokataK, et al. Microspherule protein I, Mi -2 and RET finger protein associate in the nucleolus and up-regulate ribosomal gene transcription. J Bioi Chem 2005; 280:39436-39447 .
101. Patarca R, Gordon JF, Schwartz Jet al. RPT-I, an intracellular protein from helpe r/inducer T-cells that reg ulates gene expression of interleukin 2 receptor and human immunodeficiency virus type I . Proc Natl Acad Sci USA 1988; 85:2733 -2737.
102. Gupta P, Gurudutta GU, Verma YK, et al. PU. I: an ETS family transcription factor that regulates leukemogenesis besides normal hematopoiesis. Stem Cells Dev 2006; 15:609-617.
103. Hirose S, Nishizumi 1-1, Sakano II. Pub, a novel PU. I binding protein, regulates the transcriptional activity of PU. I. Biochem Biophys Res Commun 2003; 31 1:351-360.
104. Wang Y, Li Y, Qi X, et al. TRIM45, a nove l human RBCCITRIMprotein, inhibits transcriptional activities of ElK-I and AP-1. Biochem Biophys Res Commun 2004; 323 :9-16.
105. BelliniM, Lacroix JC, Gall JG.A putative zinc-binding protein on lampbrush chromosome loops . EMBO J 1993; 12:107-1 14.
106. Beenders B, Jones PL, Bellini M. The tripartite motif of nuclear factor 7 is required for its assoc iation with trans criptional units. Mol Cell BioI 2007; 27:2615-2624.